JP2021525879A5 - - Google Patents

Info

Publication number
JP2021525879A5
JP2021525879A5 JP2020567573A JP2020567573A JP2021525879A5 JP 2021525879 A5 JP2021525879 A5 JP 2021525879A5 JP 2020567573 A JP2020567573 A JP 2020567573A JP 2020567573 A JP2020567573 A JP 2020567573A JP 2021525879 A5 JP2021525879 A5 JP 2021525879A5
Authority
JP
Japan
Prior art keywords
proadm
sample
level
trauma
fragment
Prior art date
Application number
JP2020567573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525879A (ja
JP7548823B2 (ja
JPWO2019234165A5 (https=
Filing date
Publication date
Priority claimed from EP18176268.3A external-priority patent/EP3578989A1/en
Application filed filed Critical
Publication of JP2021525879A publication Critical patent/JP2021525879A/ja
Publication of JP2021525879A5 publication Critical patent/JP2021525879A5/ja
Publication of JPWO2019234165A5 publication Critical patent/JPWO2019234165A5/ja
Priority to JP2024058795A priority Critical patent/JP2024091650A/ja
Application granted granted Critical
Publication of JP7548823B2 publication Critical patent/JP7548823B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567573A 2018-06-06 2019-06-06 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ Active JP7548823B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024058795A JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18176268.3A EP3578989A1 (en) 2018-06-06 2018-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients
EP18176268.3 2018-06-06
PCT/EP2019/064805 WO2019234165A1 (en) 2018-06-06 2019-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024058795A Division JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Publications (4)

Publication Number Publication Date
JP2021525879A JP2021525879A (ja) 2021-09-27
JP2021525879A5 true JP2021525879A5 (https=) 2022-06-15
JPWO2019234165A5 JPWO2019234165A5 (https=) 2022-06-15
JP7548823B2 JP7548823B2 (ja) 2024-09-10

Family

ID=62562975

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020567573A Active JP7548823B2 (ja) 2018-06-06 2019-06-06 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ
JP2024058795A Pending JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024058795A Pending JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Country Status (5)

Country Link
US (1) US12560620B2 (https=)
EP (2) EP3578989A1 (https=)
JP (2) JP7548823B2 (https=)
CN (1) CN112236678B (https=)
WO (1) WO2019234165A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102544219B1 (ko) * 2021-08-17 2023-06-14 한림대학교 산학협력단 코펩틴의 농도를 이용한 외상성 뇌 손상의 진단 방법
EP4658247A1 (en) * 2023-01-31 2025-12-10 Vivacelle Bio, Inc. Compositions and methods for treating hyperprocalcitonemia
CN117964711B (zh) * 2024-04-01 2024-06-11 中国科学院生物物理研究所 非天然抗菌肽及其应用
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE69602756T2 (de) 1995-08-18 2000-02-10 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
KR100425525B1 (ko) 2000-11-21 2004-03-30 재단법인서울대학교산학협력재단 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
US8298774B2 (en) * 2007-03-12 2012-10-30 Biomedica Medizinprodukte Gmbh & Co Kg Diagnosis of septic complications
PL2185937T5 (pl) * 2007-09-07 2014-12-31 Univ Zuerich Sposób wykrywania posocznicy u ludzi
ES2486268T3 (es) 2007-11-16 2014-08-18 Biocartis Nv Biomarcadores y procedimientos de diagnóstico, predicción y/o pronóstico de septicemia y usos de los mismos
US9229013B2 (en) 2009-05-05 2016-01-05 B.R.A.H.M.S Gmbh Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
US8383332B2 (en) 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
WO2012059477A1 (en) 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
EP2976646B1 (en) * 2013-03-20 2020-08-19 sphingotec GmbH Adrenomedullin to guide therapy of blood pressure decline
US20180348235A1 (en) * 2015-11-27 2018-12-06 B.R.A.H.M.S Gmbh MR-proADM as marker for the extracellular volume status of a subject
EP4231018A3 (en) 2016-07-08 2023-11-15 SphingoTec GmbH Adrenomedullin for assessing congestion in a subject with acute heart failure
RU2764766C2 (ru) * 2016-08-09 2022-01-21 Б.Р.А.Х.М.С. Гмбх Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
CA3033094A1 (en) * 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso

Similar Documents

Publication Publication Date Title
AU2024202089B2 (en) A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay
JP2021525879A5 (https=)
EP3350345B1 (en) Biomarkers for heart failure
EP3519594B1 (en) Assay for distinguishing between sepsis and systemic inflammatory response syndrome
JP6192123B2 (ja) 乳癌の予測および診断のためのバイオマーカー
RU2663724C2 (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
CN102257387A (zh) 严重脓毒病和败血性休克期间用于快速确定死亡高风险病人的方法和试剂盒
JP2024091650A5 (https=)
JP2012506245A (ja) 鉱質コルチコイドレセプターの活性化のバイオマーカー
US20250011872A1 (en) Diagnostic blood test
CN104619861A (zh) 作为血清和组织生化标志物的bag3
US20200188356A1 (en) Novel Circular RNA Biomarkers for Heart Failure
AU2016211113A1 (en) Host DNA as a biomarker of Crohn's disease
US10584383B2 (en) Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients
US20140080128A1 (en) Method for determining whether a subject is at risk of having or developing a chronic kidney disease
JP6192122B2 (ja) 結腸直腸癌診断および予測のためのバイオマーカー
JP2020533603A5 (https=)
JPWO2019234165A5 (https=)
JP2019050736A (ja) 血管炎の診断用バイオマーカー
ES2961524T3 (es) Método para diagnosticar cáncer de mama
CN114582509A (zh) 一种葡萄膜黑色素瘤预后风险评分模型及其应用
JPWO2017065206A1 (ja) 非アルコール性脂肪性肝炎マーカー及びその使用
US20140287943A1 (en) Assay for ship1 expression, activity and sequence alterations as a predictor of inflammatory bowel disease risk
WO2025244094A1 (ja) アトピー性皮膚炎患者へのデュピルマブの投与の有効性を予測する方法及びキット
WO2023020638A1 (en) Method for predicting a severity of an infectious disease and biomarker for use in carrying out the method and monitoring a therapy of an infectious disease